Evaluating Protein-protein Interaction (PPI) Networks for Diseases Pathway, Target Discovery, and Drug-design Using `In silico Pharmacology`

Author(s): Chiranjib Chakraborty, George Priya Doss. C, Luonan Chen, Hailong Zhu

Journal Name: Current Protein & Peptide Science

Volume 15 , Issue 6 , 2014

Become EABM
Become Reviewer


In silico pharmacology is a promising field in the current state-of drug discovery. This area exploits “proteinprotein Interaction (PPI) network analysis for drug discovery using the drug “target class”. To document the current status, we have discussed in this article how this an integrated system of PPI networks contribute to understand the disease pathways, present state-of-the-art drug target discovery and drug discovery process. This review article enhances our knowledge on conventional drug discovery and current drug discovery using in silico techniques, best “target class”, universal architecture of PPI networks, the present scenario of disease pathways and protein-protein interaction networks as well as the method to comprehend the PPI networks. Taken all together, ultimately a snapshot has been discussed to be familiar with how PPI network architecture can used to validate a drug target. At the conclusion, we have illustrated the future directions of PPI in target discovery and drug-design.

Keywords: PPI network, drug discovery.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Page: [561 - 571]
Pages: 11
DOI: 10.2174/1389203715666140724090153
Price: $65

Article Metrics

PDF: 45